During this year's MEB Science Day, several speakers reflected on 25 years of pharmacovigilance. Here we share some of the presentations, for which the speakers cordially gave their permission to share them:

The nature of signals

  • Prof. dr. Eugène van Puijenbroek
    Head Science and Research at the Netherlands Pharmacovigilance Centre and Professor of Pharmacovigilance at University Groningen


Pharmacovigilance : looking towards the future

  • Dr. Sabine Straus
    Chair Pharmacovigilance Risk Assessment Committee of the European Medicines Agency 


'Regulatory safety learning driven by the mechanism of action: the case of TNF-α inhibitors'

  • Lotte Minnema
    PhD Candidate Drug Regulatory Science, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University


'Introduction or discontinuation of additional Risk Minimalisation Measures during the life cycle of medicines in Europe'

  • Remy Francisca
    PhD Candidate, Erasmus Medical Centre, Rotterdam


'Post-approval regulatory learning about benefits and risks'

  • Lourens Bloem
    PhD Candidate Drug Regulatory Science, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University